Insider Transactions in Q3 2023 at Theravance Biopharma, Inc. (TBPH)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 14
2023
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
2,482
-0.73%
|
$22,338
$9.89 P/Share
|
|
Aug 22
2023
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Open market or private sale
|
Direct |
1,807
-0.53%
|
$16,263
$9.47 P/Share
|
|
Aug 20
2023
|
Brett A. Grimaud SVP, GEN COUNSEL AND SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
8,912
-3.03%
|
$80,208
$9.7 P/Share
|
|
Aug 20
2023
|
Aziz Sawaf SVP & CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
7,114
-2.64%
|
$64,026
$9.7 P/Share
|
|
Aug 20
2023
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,804
-0.97%
|
$142,236
$9.7 P/Share
|
|
Aug 20
2023
|
Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS |
SELL
Payment of exercise price or tax liability
|
Direct |
10,460
-2.96%
|
$94,140
$9.7 P/Share
|
|
Aug 20
2023
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Payment of exercise price or tax liability
|
Direct |
10,461
-2.99%
|
$94,149
$9.7 P/Share
|
|
Aug 11
2023
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
2,322
-0.66%
|
$20,898
$9.99 P/Share
|
|
Jul 14
2023
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
2,322
-0.66%
|
$20,898
$9.84 P/Share
|